Haemophilus influenzae type B vaccine

The Hib vaccine is a vaccine used to protect against Haemophilus influenzae type b (Hib). It is recommended for all infants and children up to age five, as well as for adults who have certain medical conditions. The Hib vaccine is usually given at two, four and six months of age, with a booster dose at 12 to 15 months of age. The Hib vaccine is very effective, and has led to a dramatic reduction in cases of Hib disease.

Haemophilus type-b

Haemophilus type-b conjugate

Haemophilus influenzae type B vaccine

The Haemophilus influenzae type B vaccine, also commonly known as the Hib vaccine, is a vaccine that protects against infection by Haemophilus influenzae type B bacteria. This bacteria can cause serious illnesses, particularly in young children.

Here's a breakdown of the Hib vaccine:

  • Purpose: Provides immunity to Haemophilus influenzae type B which can cause meningitis, pneumonia, epiglottitis (inflammation of the upper airway), bloodstream infections, and infections of the bones and joints.
  • Effectiveness: Thanks to widespread vaccination programs, Hib disease rates have declined dramatically. In countries that routinely include Hib vaccine in their childhood immunization schedule, severe Hib infections have decreased by more than 90%.
  • Schedule: The Hib vaccine is typically given in a series of injections during infancy and early childhood. The exact number of doses and timing can vary depending on the specific vaccine used and your child's age when they start the series. Generally, infants receive doses at 2 months, 4 months, and 6 months of age, with a booster dose at 12-15 months.
  • Types: The Hib vaccine can be administered as a standalone vaccine or combined with other childhood vaccines like diphtheria, tetanus, pertussis (whooping cough), and polio (DTaP-IPV/Hib).

Here are some additional points to consider about the Hib vaccine:

  • Safety: The Hib vaccine is considered very safe and effective. Mild side effects like redness, swelling, or tenderness at the injection site are common, but serious side effects are extremely rare.
  • Recommendation: The Centers for Disease Control and Prevention (CDC) recommends Hib vaccination for all children younger than 5 years old in the United States.
  • Age limit: While primarily recommended for young children, unvaccinated older children and adults with certain medical conditions or those who receive a bone marrow transplant may also benefit from Hib vaccination.

It's important to consult with your doctor about the Hib vaccine schedule and any questions you may have to determine if it's right for you or your child.
 

Anatomical Therapeutic Chemical Classification
J - Antiinfectives for systemic use
J07 Vaccines
J07A - Bacterial vaccines
J07AG Haemophilus influenzae B vaccines
External Links